Henry Schein (NASDAQ:HSIC) Given Outperform Rating at Barrington Research

Henry Schein (NASDAQ:HSICGet Free Report)‘s stock had its “outperform” rating reissued by investment analysts at Barrington Research in a research report issued on Wednesday,Benzinga reports. They currently have a $90.00 price target on the stock. Barrington Research’s price objective suggests a potential upside of 18.70% from the stock’s previous close.

Several other equities analysts have also commented on HSIC. Wells Fargo & Company began coverage on Henry Schein in a research report on Friday, February 14th. They set an “equal weight” rating and a $80.00 price target on the stock. Mizuho assumed coverage on shares of Henry Schein in a research report on Wednesday, December 4th. They set a “neutral” rating and a $75.00 target price on the stock. Jefferies Financial Group lifted their price target on shares of Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a research note on Thursday, January 23rd. Bank of America raised shares of Henry Schein from an “underperform” rating to a “buy” rating and upped their price objective for the company from $69.00 to $84.00 in a research report on Monday, January 6th. Finally, StockNews.com raised Henry Schein from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. Eight analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $80.09.

Read Our Latest Report on HSIC

Henry Schein Stock Performance

Shares of HSIC stock opened at $75.82 on Wednesday. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. The company has a market cap of $9.45 billion, a PE ratio of 31.20, a P/E/G ratio of 2.13 and a beta of 0.91. The company’s fifty day simple moving average is $74.25 and its 200-day simple moving average is $72.43. Henry Schein has a 52 week low of $63.67 and a 52 week high of $82.63.

Henry Schein (NASDAQ:HSICGet Free Report) last announced its quarterly earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.23 by ($0.04). The company had revenue of $3.19 billion during the quarter, compared to analyst estimates of $3.25 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The firm’s revenue for the quarter was up 5.8% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.66 earnings per share. As a group, equities research analysts anticipate that Henry Schein will post 4.74 EPS for the current year.

Institutional Investors Weigh In On Henry Schein

Institutional investors have recently modified their holdings of the business. Mackenzie Financial Corp boosted its stake in Henry Schein by 97.2% in the fourth quarter. Mackenzie Financial Corp now owns 8,819 shares of the company’s stock valued at $610,000 after acquiring an additional 4,348 shares during the period. Forum Financial Management LP acquired a new position in Henry Schein during the 4th quarter valued at approximately $221,000. Toronto Dominion Bank grew its stake in Henry Schein by 6.7% during the 4th quarter. Toronto Dominion Bank now owns 66,997 shares of the company’s stock worth $4,636,000 after buying an additional 4,218 shares during the last quarter. GF Fund Management CO. LTD. acquired a new stake in Henry Schein in the fourth quarter worth $194,000. Finally, Investment Management Corp VA ADV bought a new stake in Henry Schein in the fourth quarter valued at $32,000. Institutional investors own 96.62% of the company’s stock.

About Henry Schein

(Get Free Report)

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Further Reading

Analyst Recommendations for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.